We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+20.46%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$648M
AUM Growth
+$91.1M
Cap. Flow
-$1.29M
Cap. Flow %
-0.2%
Top 10 Hldgs %
24.72%
Holding
510
New
18
Increased
1
Reduced
8
Closed
6

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$3.14M
2
CNXC icon
Concentrix
CNXC
+$594K
3
UMBF icon
UMB Financial
UMBF
+$257K
4
MAGN
Magnera Corp
MAGN
+$247K
5
INVX
Innovex International
INVX
+$227K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.17M
2
MSFT icon
Microsoft
MSFT
+$1.59M
3
IMMU
Immunomedics Inc
IMMU
+$1.27M
4
TMUS icon
T-Mobile US
TMUS
+$741K
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$736K

Sector Composition

Rank Sector Weight
1 Technology 24.96%
2 Healthcare 13.05%
3 Financials 12.76%
4 Industrials 12.22%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
101
Becton Dickinson
BDX
$46.9B
$1.52M 0.23%
6,234
– –
SAM icon
102
Boston Beer
SAM
$1.92B
$1.49M 0.23%
1,500
– –
GD icon
103
General Dynamics
GD
$104B
$1.49M 0.23%
10,000
– –
SHYF
104
DELISTED
The Shyft Group
SHYF
$1.48M 0.23%
52,000
– –
GE icon
105
GE Aerospace
GE
$391B
$1.47M 0.23%
27,332
– –
CHGG icon
106
Chegg
CHGG
$115M
$1.45M 0.22%
16,000
– –
RSG icon
107
Republic Services
RSG
$63.9B
$1.45M 0.22%
15,000
– –
TGTX icon
108
TG Therapeutics
TGTX
$7.46B
$1.41M 0.22%
27,000
– –
CB icon
109
Chubb
CB
$134B
$1.39M 0.21%
9,028
– –
APD icon
110
Air Products & Chemicals
APD
$65.6B
$1.37M 0.21%
5,000
– –
PH icon
111
Parker-Hannifin
PH
$125B
$1.36M 0.21%
5,000
– –
AVB icon
112
AvalonBay Communities
AVB
$27B
$1.35M 0.21%
8,407
– –
DUK icon
113
Duke Energy
DUK
$96.9B
$1.35M 0.21%
14,733
– –
DOW icon
114
Dow Inc
DOW
$21.9B
$1.34M 0.21%
24,071
– –
AFL icon
115
Aflac
AFL
$63.7B
$1.33M 0.21%
30,000
– –
SCHW
116
Charles Schwab
SCHW
$185B
$1.33M 0.2%
25,000
– –
CPK icon
117
Chesapeake Utilities
CPK
$3.19B
$1.3M 0.2%
12,000
– –
BSX icon
118
Boston Scientific
BSX
$71.1B
$1.29M 0.2%
36,000
– –
BHVN
119
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.29M 0.2%
15,000
– –
XLRN
120
DELISTED
Acceleron Pharma
XLRN
$1.28M 0.2%
10,000
– –
KLIC icon
121
Kulicke & Soffa
KLIC
$4.91B
$1.27M 0.2%
40,000
– –
MTCH icon
122
Match Group
MTCH
$9.62B
$1.26M 0.2%
8,363
– –
EBAY icon
123
eBay
EBAY
$48.7B
$1.26M 0.19%
25,000
– –
DHR icon
124
Danaher
DHR
$137B
$1.25M 0.19%
6,362
– –
AEP icon
125
American Electric Power
AEP
$69.9B
$1.23M 0.19%
14,760
– –
3 4
5
6 7

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2020 Portfolio in Review

As of Q4 2020, NJ State Employees Deferred Compensation Plan held 510 positions worth $648M, up 16% from $557M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 4.7%. NJ State Employees Deferred Compensation Plan opened 18 new positions and exited 6, leaving the 510-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2020 buy was RTX Corp: 47,715 shares worth $3.41M.
  • NJ State Employees Deferred Compensation Plan added most to Viatris in Q4 2020, an estimated $105K increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2020 reduction was Apple, cutting an estimated $2.17M.
  • NJ State Employees Deferred Compensation Plan fully exited Immunomedics Inc in Q4 2020, selling an estimated $1.27M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 25% of its $648M portfolio in Q4 2020.
  • NJ State Employees Deferred Compensation Plan opened 18 new positions and closed 6 in Q4 2020.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 16% quarter-over-quarter to $648M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2020, filed 2 Feb 2021.